Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of BCR-ABL Negative ALL in Adults According to MRD and Genetics

NCT04179929 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT04179929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04179929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of BCR-ABL Negative ALL in Adults According to MRD and Genetics
Lead sponsor
PETHEMA Foundation
Phase
Not applicable
Overall status
Recruiting
Start date
November 25, 2019
Completion date
February 28, 2027
Enrollment
300 (estimated)
Sites
108

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia